Normal görünüm
MARC görünümü
- Kirst, Herbert A.
Giriş Personal Name
001 - CONTROL NUMBER
- control field: 101351
003 - CONTROL NUMBER IDENTIFIER
- control field: DLC
005 - DATE AND TIME OF LATEST TRANSACTION
- control field: 20160525120318.0
008 - FIXED-LENGTH DATA ELEMENTS
- fixed length control field: 930601n| acannaab |a aaa b
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
- LC control number: n 93802028
040 ## - CATALOGING SOURCE
- Original cataloging agency: DNLM
- Language of cataloging: eng
- Transcribing agency: DLC
- Modifying agency: DLC
- Modifying agency: DNLM
- Modifying agency: DLC
100 1# - HEADING--PERSONAL NAME
- Personal name: Kirst, Herbert A.
400 1# - SEE FROM TRACING--PERSONAL NAME
- Personal name: Kirst, H. A.
- Fuller form of name: (Herbert A.)
670 ## - SOURCE DATA FOUND
- Source citation: Antibiotics and antiviral compounds, c1993:
- Information found: CIP t.p. (Herbert Kirst) t.p. verso, etc. (Dr.; Lilly Research Laboratories, Lilly Corp. Cent., Indianapolis, Indiana, USA; Herbert A. Kirst) book t.p. (Herbert A. Kirst)
670 ## - SOURCE DATA FOUND
- Source citation: Enzyme technologies for pharmaceutical and biotechnological applications, 2001:
- Information found: CIP t.p. (Herbert A. Kirst) data sheet (b. 09-22-44)
670 ## - SOURCE DATA FOUND
- Source citation: Macrolide antibiotics, c2001:
- Information found: CIP t.p. (H.A. Kirst) t.p. verso, etc. (Herbert A. Kirst, Elanco Animal Health, Greenfield, Indiana, USA; b. September 22, 1944)
-baunlogo.png?alt=media&token=2b1f50b7-298a-48ee-a2b1-6fcf8e70b387)